Journal of the American Society of Hypertension
Volume 1, Issue 2 , Pages 135-144 , March 2007

Blood pressure, cognitive dysfunction, and dementia

  • Hossein Eftekhari, MD
    • ,
  • Seth Uretsky, MD
    • ,
  • Franz H. Messerli, MD, FACC

      Affiliations

    • Corresponding Author InformationCorresponding author: Franz H. Messerli, MD, FACC, Director, Division of Hypertension, Department of Cardiology, St. Luke’s-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, 1000 Amsterdam Avenue, New York, New York 10019.

Received 5 December 2006 ,Accepted 16 January 2007.

References 

  1. Hebert LE, Beckett LA, Scherr PA, et al. Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord. 2001;15:169–173
  2. Fratiglioni L, De Ronchi D, Aguero-Torres H. Worldwide prevalence and incidence of dementia. Drugs Aging. 1999;15:365–375
  3. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset. Am J Public Health. 1998;88:1337–1342
  4. Jorm AF, Jolley D. The incidence of dementia: a meta-analysis. Neurology. 1998;51:728–733
  5. Canadian Study of Health and Aging: study methods and prevalence of dementia. CMAJ. 1994;150:899–913
  6. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies (Report of the NINDS-AIREN international workshop). Neurology. 1993;43:250–260
  7. van Duijn CM, Stijnen T, Hofman A. Risk factors for Alzheimer’s disease: a collaborative re-analysis of case-control studies. Int J Epidemiol. 1991;20(suppl 2):2–73
  8. Launer LJ, Andersen K, Dewey ME, et al. Rates and risk factors for dementia and Alzheimer’s disease: results from EURODEM pooled analyses. Neurology. 1999;52:78–84
  9. Martin J. Age-related changes in vascular responses: a review. Mech Aging Dev. 1995;79:71–114
  10. Faraci FM, Heistad DD. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev. 1998;78:53–97
  11. Mooradian AD. Central nervous system complications of diabetes mellitus: a perspective from the blood-brain barrier. Brain Res Rev. 1997;23:210–218
  12. Kalmijn S, van Boxtel MP, Verschuren MW, et al. Cigarette smoking and alcohol consumption in relation to cognitive performance in middle age. Am J Epidemiol. 2002;156:936–944
  13. Miller JW, Green R, Mungas DM, et al. Homocysteine, vitamin B6, and vascular disease in AD patients. Neurology. 2002;58:1471–1475
  14. Roman GC. Vascular dementia prevention: a risk factor analysis. Cerebrovasc Dis. 2005;20(suppl 2):91–100
  15. Di Carlo A, Baldereschi M, Amaducci L, et al. Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability (The Italian Longitudinal Study on Aging). J Am Geriatr Soc. 2000;48:775–782
  16. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease (Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias). Lancet. 1990;335:765–774
  17. Miller VT. Lacunar stroke: a reassessment. Arch Neurol. 1983;40:129–134
  18. Salerno JA, Murphy DG, Horwitz B, et al. Brain atrophy in hypertension: A volumetric magnetic resonance imaging study. Hypertension. 1992;20:340–348
  19. Sparks DL, Scheff SW, Liu H, et al. Increased incidence of neurofibrillary tangles (NFT) in nondemented individuals with hypertension. J Neurol Sci. 1995;131:162–169
  20. Petrovitch H, White LR, Izmirilian G, et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS (Honolulu-Asia Aging Study). Neurobiol Aging. 2000;21:57–62
  21. van Boxtel MP, Gaillard C, Houx PJ, et al. Can the blood pressure predict cognitive task performance in a healthy population sample?. J Hypertens. 1997;15:1069–1076
  22. Budge MM, de Jager C, Hogervorst E, et al. Oxford Project To Investigate Memory and Ageing (OPTIMA) (Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people). J Am Geriatr Soc. 2002;50:2014–2018
  23. Kuo HK, et al. Effect of blood pressure on cognitive functions in elderly persons. J Gerontol A Biol Sci Med Sci. 2004;59:1191–1194
  24. Suhr JA, Stewart JC, France CR. The relationship between blood pressure and cognitive performance in the Third National Health and Nutrition Examination Survey (NHANES III). Psychosom Med. 2004;66:291–297
  25. Swan GE, Carmelli D, Larue A. Systolic blood pressure tracking over 25 to 30 years and cognitive performance in older adults. Stroke. 1998;29:2334–2340
  26. Launer LJ, Masaki K, Petrovitch H, et al. The association between midlife blood pressure levels and late-life cognitive function (The Honolulu-Asia Aging Study). JAMA. 1995;274:1846–1851
  27. Knopman D, Boland LL, Mosley T, et al. Atherosclerosis Risk in Communities (ARIC) Study Investigators Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology. 2001;56:42–48
  28. Wu C, Zhou D, Wen C, et al. Relationship between blood pressure and Alzheimer’s disease in Linxian County, China. Life Sci. 2003;72:1125–1133
  29. Bellew KM, Pigeon JG, Stang PE, et al. Hypertension and the rate of cognitive decline in patients with dementia of the Alzheimer type. Alzheimer Dis Assoc Disord. 2004;18:208–213
  30. Richards SS, Emsley CL, Roberts J, et al. The association between vascular risk factor-mediating medications and cognition and dementia diagnosis in a community-based sample of African-Americans. J Am Geriatr Soc. 2000;48:1035–1041
  31. Hajjar I, Keown M, Frost B. Antihypertensive agents for aging patients who are at risk for cognitive dysfunction. Curr Hypertens Rep. 2005;7:466–473
  32. Peila R, White LR, Masaki K, et al. Reducing the risk of dementia (Efficacy of long-term treatment of hypertension). Stroke. 2006;37:1165–1170
  33. Hajjar I, Catoe H, Sixta S, et al. Cross-sectional and longitudinal association between antihypertensive medications and cognitive impairment in an elderly population. J Gerontol A Biol Sci Med Sci. 2005;60:67–73
  34. in’t Veld BA, Ruitenberg A, Hofman A, et al. Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging. 2001;22:407–412
  35. Khachaturian AS, Zandi PP, Lyketsos CG, et al. Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch Neurol. 2006;63:686–692
  36. The Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group. Rationale and design of a randomized clinical trial on prevention of stroke in isolated systolic hypertension. J Clin Epidemiol. 1988;41:1197–1208
  37. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension (Final results of the Systolic Hypertension in the Elderly Program (SHEP)). JAMA. 1991;265:3255–3264
  38. Applegate WB, Pressel S, Wittes J, et al. Impact of the treatment of isolated systolic hypertension on behavioral variables (Results from the systolic hypertension in the elderly program). Arch Intern Med. 1994;154:2154–2160
  39. Di Bari M, Pahor M, Franse LV, et al. Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial. Am J Epidemiol. 2001;153:72–78
  40. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ. 1992;304:405–412
  41. Prince MJ, Bird AS, Blizard RA, et al. The cognitive function of older patients affected by antihypertensive treatment? (Results from 54 months of the Medical Research Council’s trial of hypertension in older adults). BMJ. 1996;312:801–805
  42. Starr JM, Whalley LJ, Deary IJ. The effects of antihypertensive treatment on cognitive function: results from the HOPE study. J Am Geriatr Soc. 1996;44:411–415
  43. Tzourio C, Anderson C, Chapman N, et al. The PROGRESS Collaborative Group Effect of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med. 2003;163:1069–1075
  44. Lithell H, Hansson L, Skoog I, et al. SCOPE Study Group The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens. 2003;21:875–886
  45. Fogari R, Mugellini A, Zoppi A, et al. Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension. Eur J Clin Pharmacol. 2004;59:863–8682004 Jan 28;[E-pub]
  46. Fogari R, Mugellini A, Zoppi A, et al. Influence of losartan and atenolol on memory function in very elderly hypertensive patients. J Hum Hypertens. 2003;17:781–785
  47. Forette F, Seux ML, Staessen JA, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998;352:1347–1351
  48. Forette F, Seux ML, Staessen JA, et al. Systolic Hypertension in Europe Investigators The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med. 2002;162:2046–2052
  49. Hanon O, Pequignot R, Seux ML, et al. Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints. J Hypertens. 2006;24:2101–2107
  50. McGuinness B, Todd S, Passmore P, et al. The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease (review). Cochrane Database Syst Rev. 2006;(2):CD004034
  51. Morris MC, Scherr PA, Hebert LE, et al. The cross-sectional association between blood pressure and Alzheimer’s disease in a biracial community population of older persons. J Gerontol A Biol Sci Med Sci. 2000;55:M130–M136
  52. Verghese J, Lipton RB, Hall CB, et al. Low blood pressure and the risk of dementia in very old individuals. Neurology. 2003;61:1667–1672
  53. Guo Z, et al. Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ. 1996;312:805–808
  54. Landin K, Blennow K, Wallin A, et al. Low blood pressure and blood glucose levels in Alzheimer’s disease (Evidence for a hypometabolic disorder?). Intern Med. 1993;233:357–363
  55. Elmstahl S, Petersson M, Lilja B, et al. Autonomic cardiovascular responses to tilting in patients with Alzheimer’s disease and in healthy elderly women. Age Aging. 1992;21:301–307
  56. Waldstein SR, Giggey PP, Thayer JF, et al. Nonlinear relations of blood pressure to cognitive function: the Baltimore Longitudinal Study of Aging. Hypertension. 2005;45:374–379
  57. Morris MC, Scherr PA, Hebert LE, et al. Association between blood pressure and cognitive function in a biracial community population of older persons. Neuroepidemiology. 2002;21:123–130
  58. Glynn RJ, Beckett LA, Hebert LE, et al. Current and remote blood pressure and cognitive decline. JAMA. 1999;281:438–445
  59. Launer LJ. Demonstrating the case that AD is a vascular disease: epidemiologic evidence. Aging Res Rev. 2002;1:61–77
  60. De la Torre JC. Is Alzheimer’s disease a neurodegenerative or a vascular disorder?. Data, dogma, and dialectics, Lancet Neurol. 2004;3:184–190
  61. Esiri MM, Nagy Z, Smith MZ, et al. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer’s disease. Lancet. 1999;354:919–920
  62. Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348:1215–1222
  63. Sinforiani E, Curci R, Fancellu R, et al. Neuropsychological changes after carotid endarterectomy. Funct Neurol. 2001;16:329–336
  64. Lunn S, Crawley F, Harrison FM, et al. Impact of carotid endarterectomy upon cognitive functioning: a systematic review of the literature. Cerebrovasc Dis. 1999;9:74–81
  65. Vagnucci AH, Li WW. Alzheimer’s disease and angiogenesis. Lancet. 2003;361:605–608
  66. Kalback W, Esh C, Castano EM, et al. Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer’s disease. Neurol Res. 2004;26:525–539
  67. Franklin SS, Gustin W, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure: the Framingham Heart Study. Circulation. 1997;96:308–315
  68. Arnett DK, Boland LL, Evans GW, et al. Hypertension and arterial stiffness: the Atherosclerosis Risk in Communities Study. Am J Hypertens. 2000;13:317–323
  69. Hofman A, Breteler MM, Bots ML, et al. Atherosclerosis, apolipoprotein E and prevalence of dementia and Alzheimer’s disease in the Rotterdam Study. Lancet. 1997;349:151–154
  70. Aliev G, Seyidova D, Neal ML, et al. Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice. Ann NY Acad Sci. 2002;977:45–46
  71. De la Torre JC, Stefano GB. Evidence that Alzheimer’s disease is a microvascular disorder: role of constitutive nitric oxide. Brain Res Rev. 2000;34:119–136

 Conflict of interest: none.

PII: S1933-1711(07)00015-0

doi: 10.1016/j.jash.2007.01.003

Journal of the American Society of Hypertension
Volume 1, Issue 2 , Pages 135-144 , March 2007

Article Tools